{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:39:08Z","timestamp":1778884748365,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2706-0","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T12:19:24Z","timestamp":1504527564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada"],"prefix":"10.1186","volume":"17","author":[{"given":"Kamila","family":"Romanowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie Y.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Z.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"2706_CR1","unstructured":"World Health Organization. Global tuberculosis report 2016. [Internet]. Available from: \n                    http:\/\/www.who.int\/tb\/publications\/global_report\/en\/\n                    \n                  . Accessed 13 Oct 2016."},{"key":"2706_CR2","first-page":"939","volume":"121","author":"A Jindani","year":"1980","unstructured":"Jindani A, Aber VR, Edwards EA, Mitchison DA. The Early Bactericidal Activity of Drugs in Patients with Pulmonary Tuberculosis 1, 2. Am Rev Respir Dis. 1980;121:939\u201349.","journal-title":"Am Rev Respir Dis"},{"key":"2706_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/jac\/45.6.859","volume":"45","author":"FA Sirgel","year":"2000","unstructured":"Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN, et al. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother. 2000;45:859\u201370.","journal-title":"J Antimicrob Chemother"},{"key":"2706_CR4","doi-asserted-by":"publisher","first-page":"e22927","DOI":"10.1371\/journal.pone.0022927","volume":"6","author":"HE Jenkins","year":"2011","unstructured":"Jenkins HE, Zignol M, Cohen T. Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994\u20132009. PLoS One. 2011;6:e22927.","journal-title":"PLoS One"},{"key":"2706_CR5","doi-asserted-by":"publisher","first-page":"e1000146","DOI":"10.1371\/journal.pmed.1000146","volume":"6","author":"D Menzies","year":"2009","unstructured":"Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med. 2009;6:e1000146.","journal-title":"PLoS Med"},{"key":"2706_CR6","doi-asserted-by":"publisher","first-page":"e1000150","DOI":"10.1371\/journal.pmed.1000150","volume":"6","author":"D Menzies","year":"2009","unstructured":"Menzies D, Benedetti A, Paydar A, Royce S, Pai M, Burman W, et al. Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med. 2009;6:e1000150.","journal-title":"PLoS Med"},{"key":"2706_CR7","unstructured":"WHO | Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis [Internet]. Available from: \n                    http:\/\/www.who.int\/tb\/publications\/pmdt_companionhandbook\/en\/\n                    \n                  . Accessed 25 Aug 2016."},{"key":"2706_CR8","unstructured":"American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of Tuberculosis [Internet]. Available from: \n                    http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5211a1.htm\n                    \n                  . Accessed 21 Apr 2016."},{"key":"2706_CR9","unstructured":"The Public Health Agency of Canada, Canadian Thoracic Society. Canadian Tuberculosis Standards, 7th Edition 2013. Canadian Respiratory Guidelines [Internet]. Available from: \n                    http:\/\/www.respiratoryguidelines.ca\/tb-standards-2013\n                    \n                  . Accessed 15 Apr 2016."},{"key":"2706_CR10","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1378\/chest.119.6.1730","volume":"119","author":"P Escalante","year":"2001","unstructured":"Escalante P, Graviss EA, Griffith DE, Musser JM, Awe RJ. Treatment of isoniazid-resistant tuberculosis in southeastern Texas. CHEST J. 2001;119:1730\u20136.","journal-title":"CHEST J"},{"key":"2706_CR11","series-title":"QJM","first-page":"hcu139","volume-title":"Isoniazid-Resistant Tuberculosis in Birmingham, United Kingdom, 1999\u20132010","author":"M Munang","year":"2014","unstructured":"Munang M, Kariuki M, Dedicoat M. Isoniazid-Resistant Tuberculosis in Birmingham, United Kingdom, 1999\u20132010, QJM; 2014. p. hcu139."},{"key":"2706_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1086\/595689","volume":"48","author":"A Cattamanchi","year":"2009","unstructured":"Cattamanchi A, Dantes RB, Metcalfe JZ, Jarlsberg LG, Grinsdale J, Kawamura LM, et al. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis. 2009;48:179\u201385.","journal-title":"Clin Infect Dis"},{"key":"2706_CR13","unstructured":"BC Centre for Disease Control. TB annual report 2014 [Internet]. Available from: \n                    http:\/\/www.bccdc.ca\/resource-gallery\/Documents\/Statistics%20and%20Research\/Statistics%20and%20Reports\/TB\/TB_Annual_Report_2014.pdf\n                    \n                  . Accessed 1 June 2016."},{"key":"2706_CR14","unstructured":"CLSI. Susceptibility Testing of Mycobacteria, Nocardia e, and Other Aerobic Actinomycetes; Approved Standard\u2014Second Edition. CLSI document M24-A2. Wayne: Clinical and Laboratory Standards Institute; 2011. [Internet]. Available from:\u00a0\n                    https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m24\/\n                    \n                  . Accessed 2 Sept 2016."},{"key":"2706_CR15","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/JCM.01392-06","volume":"44","author":"P Supply","year":"2006","unstructured":"Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, et al. Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44:4498\u2013510.","journal-title":"J Clin Microbiol"},{"key":"2706_CR16","first-page":"452","volume":"60","author":"D Bang","year":"2010","unstructured":"Bang D, Andersen PH. Andersen, AAse Bengaard, Thomsen V\u00d8. Isoniazid-resistant tuberculosis in Denmark: mutations, transmission and treatment outcome. J Inf Secur. 2010;60:452\u20137.","journal-title":"J Inf Secur"},{"key":"2706_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cid\/cir406","volume":"53","author":"KR Jacobson","year":"2011","unstructured":"Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray MB. Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province. South Africa Clin Infect Dis. 2011;53:369\u201372.","journal-title":"South Africa Clin Infect Dis"},{"key":"2706_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/AAC.01377-15","volume":"60","author":"H Lee","year":"2016","unstructured":"Lee H, Jeong B-H, Park HY, Jeon K, Huh HJ, Lee NY, et al. Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2016;60:471\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2706_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cmi.2014.08.008","volume":"21","author":"J-Y Chien","year":"2015","unstructured":"Chien J-Y, Chen Y-T, Wu S-G, Lee J-J, Wang J-Y, Yu C-J. Treatment outcome of patients with isoniazid mono-resistant tuberculosis. Clin Microbiol Infect. 2015;21:59\u201368.","journal-title":"Clin Microbiol Infect"},{"key":"2706_CR20","unstructured":"World Health Organization. Treatment of tuberculosis: guidelines for national programmes [Internet]. Available from: \n                    http:\/\/www.who.int\/tb\/features_archive\/new_treatment_guidelines_may2010\/en\/\n                    \n                  . Accessed 21 Apr 2016."},{"key":"2706_CR21","unstructured":"Nolan C. M, Goldberg S. V. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Int J Tuberc Lung Dis 2002;6:952\u2013958."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2706-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T13:02:16Z","timestamp":1536584536000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2706-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2706"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2706-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]},"article-number":"604"}}